EUVIMEDEUVIMED entdecken
Open Access · CC0

Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays

Nicholas Wiese iD, William Hendley, Basit Jafri, Kathryn A V Jones, Giovanna Sifontes, Sandra Valdez, Yiting Zhang, Bernardo A Mainou iD

PLOS One · 23.02.2026 · 21 (2) · e0343816

DOI: 10.1371/journal.pone.0343816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 23.02.2026. Verfasst von Nicholas Wiese und 7 weiteren Autor:innen. Beteiligte Einrichtung: Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America. Hauptthemen laut MEDLINE: Poliovirus, Neutralization Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poliovirus eradication efforts have relied on effective vaccination campaigns and stringent laboratory containment of poliovirus strains. Serological testing is the primary means to address population immunity, vaccine efficacy, and individual poliovirus exposures. However, strict containment requirements for Sabin type 2 and wild poliovirus types 2 & 3 limit access to serological testing. To address these limitations, we evaluated the performance of hyper-attenuated, temperature-sensitive S19 poliovirus strains (S19-PV), which retain the antigenic characteristics of Sabin and Salk strains but can be handled under biosafety level 2 (BSL-2) conditions. Using a modified microneutralization assay, we performed a comparative validation of S19-PVs to their Sabin and wild-type counterparts using WHO international standards, in-house control reagents, and human sera. Neutralizing antibody titers showed strong concordance between S19-PV and reference strains (R² = 0.93–0.99), with high intra- and inter-assay reproducibility (CVs < 10%). Our findings demonstrate that S19-PV strains are antigenically equivalent to Sabin and wild-type viruses and suitable for use in neutralization assays to determine levels of poliovirus neutralizing antibodies outside of strict containment laboratories. Adoption of these strains can significantly expand global capacity for poliovirus serological testing, supporting surveillance and immunization activities in the final stages of poliovirus eradication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PoliovirusNeutralization TestsHumansAntibodies, NeutralizingAntibodies, ViralPoliomyelitisReproducibility of ResultsVaccines, Attenuated

Substanzen

Antibodies, NeutralizingAntibodies, ViralVaccines, Attenuated

Autor:innen und Institutionen

  • Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
  • United States Public Health Service, Rockville, Maryland, United States of America.
  • Tanaq Contracting Agency to the Division of Viral Diseases, Atlanta, GeorgiaUnited States of America.

ORCID-Profile: Nicholas Wiese, Bernardo A Mainou

Zitieren

APA

Wiese, N., Hendley, W., Jafri, B., Jones, K. A. V., Sifontes, G., Valdez, S., Zhang, Y., & Mainou, B. A. (2026). Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays. PLOS One, 21(2), e0343816. https://doi.org/10.1371/journal.pone.0343816

Vancouver

Wiese N, Hendley W, Jafri B, Jones KAV, Sifontes G, Valdez S, et al. Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays. PLOS One. 2026;21(2):e0343816. doi:10.1371/journal.pone.0343816

BibTeX
@article{Wiese2026,
  author = {Wiese, Nicholas and Hendley, William and Jafri, Basit and Jones, Kathryn A V and Sifontes, Giovanna and Valdez, Sandra and Zhang, Yiting and Mainou, Bernardo A},
  title = {Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {e0343816},
  doi = {10.1371/journal.pone.0343816}
}
Kostenlos starten →